Exercise training increases anabolic and attenuates catabolic and apoptotic processes in aged skeletal muscle of male rats

Experimental Gerontology

Volumn 67, Issue , 2015, Pages 9-14

  Ziaaldini, Mohammad Mosaferi ^a   Koltai, Erika ^a   Csende, Zsolt ^a   Goto, Sataro ^b   Boldogh, Istvan ^c   Taylor, Albert W ^d   Radak, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b JUNTENDO UNIVERSITY   (Japan)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aging; Exercise; Follistatin; Myostatin; Reactive oxygen species; Skeletal muscle

Indexed keywords

FOLLISTATIN; LIGASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MURF2 PROTEIN; MUSCLE RING FINGER 1 PROTEIN; MYOSTATIN; PROTEASOME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GDF8 PROTEIN, RAT;

AEROBIC EXERCISE; AGING; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CACHEXIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HORMONAL REGULATION; MALE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UBIQUITINATION; UPREGULATION; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

RATTUS;

AGING; ANIMALS; APOPTOSIS; FOLLISTATIN; MALE; MUSCLE, SKELETAL; MYOSTATIN; PHYSICAL CONDITIONING, ANIMAL; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84928730718     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2015.04.008     Document Type: Article

References (49)

1. Attisano L., Silvestri C., Izzi L., Labbe E. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. Mol. Cell. Endocrinol. 2001, 180:3-11.
2. Bijlsma A.Y., Meskers C.G., Westendorp R.G., Maier A.B. Chronology of age-related disease definitions: osteoporosis and sarcopenia. Ageing Res. Rev. 2012, 11:320-324.
3. Bonetto A., Penna F., Minero V.G., Reffo P., Bonelli G., Baccino F.M., Costelli P. Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. Curr. Cancer Drug Targets 2009, 9:608-616.
4. Boonsong T., Norton L., Chokkalingam K., Jewell K., Macdonald I., Bennett A., Tsintzas K. Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways. Biochem. Soc. Trans. 2007, 35:1310-1311.
5. Bowser M., Herberg S., Arounleut P., Shi X., Fulzele S., Hill W.D., Isales C.M., Hamrick M.W. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp. Gerontol. 2013, 48:290-297.
6. Brioche T., Kireev R.A., Cuesta S., Gratas-Delamarche A., Tresguerres J.A., Gomez-Cabrera M.C., Vina J. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 69:1110-1119.
7. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8:766-775.
8. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Calabrese E.J., Mattson M.P. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox Signal. 2010, 13:1763-1811.
9. Calabrese V., Cornelius C., Cuzzocrea S., Iavicoli I., Rizzarelli E., Calabrese E.J. Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity. Mol. Asp. Med. 2011, 32:279-304.
10. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., Cuzzocrea S., Rizzarelli E., Calabrese E.J. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim. Biophys. Acta 2012, 1822:753-783.
11. Chen X., Ruiz-Echevarria M.J. TMEFF2 modulates the AKT and ERK signaling pathways. Int. J. Biochem. Mol. Biol. 2013, 4:83-94.
12. Cornelius C., Perrotta R., Graziano A., Calabrese E.J., Calabrese V. Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a "chi". Immun. Ageing 2013, 10:15.
13. Degens H. The role of systemic inflammation in age-related muscle weakness and wasting. Scand. J. Med. Sci. Sports 2010, 20:28-38.
14. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Med. 2004, 34:809-824.
15. Dickinson J.M., Volpi E., Rasmussen B.B. Exercise and nutrition to target protein synthesis impairments in aging skeletal muscle. Exerc. Sport Sci. Rev. 2013, 41:216-223.
16. Eley H.L., Russell S.T., Tisdale M.J. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1417-E1426.
17. Favier F.B., Benoit H., Freyssenet D. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch. 2008, 456:587-600.
18. Fuentes E.N., Bjornsson B.T., Valdes J.A., Einarsdottir I.E., Lorca B., Alvarez M., Molina A. IGF-I/PI3K/Akt and IGF-I/MAPK/ERK pathways in vivo in skeletal muscle are regulated by nutrition and contribute to somatic growth in the fine flounder. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R1532-R1542.
19. Gilson H., Schakman O., Kalista S., Lause P., Tsuchida K., Thissen J.P. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E157-E164.
20. Gorgens S.W., Raschke S., Holven K.B., Jensen J., Eckardt K., Eckel J. Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells. Arch. Physiol. Biochem. 2013, 119:75-80.
21. Goto S., Naito H., Kaneko T., Chung H.Y., Radak Z. Hormetic effects of regular exercise in aging: correlation with oxidative stress. Appl. Physiol. Nutr. Metab. 2007, 32:948-953.
22. Hiona A., Leeuwenburgh C. The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp. Gerontol. 2008, 43:24-33.
23. Hitachi K., Nakatani M., Tsuchida K. Myostatin signaling regulates Akt activity via the regulation of miR-486 expression. Int. J. Biochem. Cell Biol. 2014, 47:93-103.
24. Ji L.L. Antioxidant signaling in skeletal muscle: a brief review. Exp. Gerontol. 2007, 42:582-593.
25. Kalyanaraman B., Darley-Usmar V., Davies K.J., Dennery P.A., Forman H.J., Grisham M.B., Mann G.E., Moor K., Roberts Lj 2nd, Ischiropoulos H. The Use of Fluorescence Probes to Measure Reactive Oxygen and Nitrogen Species in Cell: Challenges. Potentials and Caveats 2012, 52:1-6.
26. Koltai E., Szabo Z., Atalay M., Boldogh I., Naito H., Goto S., Nyakas C., Radak Z. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech. Ageing Dev. 2010, 131:21-28.
27. Langen R.C., Korn S.H., Wouters E.F. ROS in the local and systemic pathogenesis of COPD. Free Radic. Biol. Med. 2003, 35:226-235.
28. Lawler J.M., Hindle A. Living in a box or call of the wild? Revisiting lifetime inactivity and sarcopenia. Antioxid. Redox Signal. 2011, 15:2529-2541.
29. Llovera M., Lopez-Soriano F.J., Argiles J.M. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats. J. Natl. Cancer Inst. 1993, 85:1334-1339.
30. Mattox T.A., Young M.E., Rubel C.E., Spaniel C., Rodriguez J.E., Grevengoed T.J., Gautel M., Xu Z., Anderson E.J., Willis M.S. MuRF1 activity is present in cardiac mitochondria and regulates reactive oxygen species production in vivo. J. Bioenerg. Biomembr. 2014, 46:173-187.
31. Moriscot A.S., Baptista I.L., Bogomolovas J., Witt C., Hirner S., Granzier H., Labeit S. MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance. J. Struct. Biol. 2010, 170:344-353.
32. Nass R. Growth hormone axis and aging. Endocrinol. Metab. Clin. N. Am. 2013, 42:187-199.
33. Pak J.W., Aiken J.M. Low levels of mtDNA deletion mutations in ETS normal fibers from aged rats. Ann. N. Y. Acad. Sci. 2004, 1019:289-293.
34. Pasiakos S.M., McClung H.L., McClung J.P., Urso M.L., Pikosky M.A., Cloutier G.J., Fielding R.A., Young A.J. Molecular responses to moderate endurance exercise in skeletal muscle. Int. J. Sport Nutr. Exerc. Metab. 2010, 20:282-290.
35. Radak Z., Naito H., Kaneko T., Tahara S., Nakamoto H., Takahashi R., Cardozo-Pelaez F., Goto S. Exercise training decreases DNA damage and increases DNA repair and resistance against oxidative stress of proteins in aged rat skeletal muscle. Pflugers Arch. 2002, 445:273-278.
36. Radak Z., Chung H.Y., Naito H., Takahashi R., Jung K.J., Kim H.J., Goto S. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. FASEB J. 2004, 18:749-750.
37. Radak Z., Chung H.Y., Goto S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology 2005, 6:71-75.
38. Radak Z., Zhao Z., Goto S., Koltai E. Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA. Mol. Asp. Med. 2011, 32:305-315.
39. Radak Z., Koltai E., Taylor A.W., Higuchi M., Kumagai S., Ohno H., Goto S., Boldogh I. Redox-regulating sirtuins in aging, caloric restriction, and exercise. Free Radic. Biol. Med. 2013, 58:87-97.
40. Reid K.F., Fielding R.A. Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc. Sport Sci. Rev. 2012, 40:4-12.
41. Reid M.B., Lannergren J., Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am. J. Respir. Crit. Care Med. 2002, 166:479-484.
42. Rosen K.M., Wentworth B.M., Rosenthal N., Villa-Komaroff L. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology 1993, 133:474-481.
43. Sacheck J.M., Hyatt J.P., Raffaello A., Jagoe R.T., Roy R.R., Edgerton V.R., Lecker S.H., Goldberg A.L. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 2007, 21:140-155.
44. Sriram S., Subramanian S., Sathiakumar D., Venkatesh R., Salerno M.S., McFarlane C.D., Kambadur R., Sharma M. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-kappaB. Aging Cell 2011, 10:931-948.
45. Suryawan A., Frank J.W., Nguyen H.V., Davis T.A. Expression of the TGF-beta family of ligands is developmentally regulated in skeletal muscle of neonatal rats. Pediatr. Res. 2006, 59:175-179.
46. Tamilselvan J., Jayaraman G., Sivarajan K., Panneerselvam C. Age-dependent upregulation of p53 and cytochrome c release and susceptibility to apoptosis in skeletal muscle fiber of aged rats: role of carnitine and lipoic acid. Free Radic. Biol. Med. 2007, 43:1656-1669.
47. Thomas S.S., Mitch W.E. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin. Clin. Exp. Nephrol. 2013, 17:174-182.
48. Williamson D.L., Kubica N., Kimball S.R., Jefferson L.S. Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle. J. Physiol. 2006, 573:497-510.
49. Witt C.C., Witt S.H., Lerche S., Labeit D., Back W., Labeit S. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J. 2008, 27:350-360.